Meric Kaymak Cihan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Meric Kaymak Cihan has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Fatih Bolat
Department of Neonatology, Cumhuriyet University, Sivas, Turkey
2 shared publications - Inci Ergurhan Ilhan
Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
2 shared publications - Neriman Sarı
Department of Pediatric Hematology-Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye
2 shared publications - Turan Bayhan
Department of Pediatric Hematology/Oncology, Ankara Yildirim Beyazit University Ankara Bilkent City Hospital, Ankara, Turkey
2 shared publications Ahmet Emin Kürekçi
Division of Pediatric Hematology and Oncology, Private Lösante Children and Adults Hospital, Ankara, Turkey
1 shared publicationAhmet Sami Güven
Cumhuriyet University
1 shared publication
Latest Publications
- 11 April 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (6) , 666
EWSR1 Rearrangement in Pediatric B-Lymphoblastic Lymphoma: A Diagnostic Pitfall
- 11 April 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (6) , 666
EWSR1 Rearrangement in Pediatric B-Lymphoblastic Lymphoma: A Diagnostic Pitfall
- Open Access
- 14 March 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (2) , 93
Sleep and psychiatric problems in pediatric oncology patients: A case–control study
Objective This study primarily aimed to investigate sleep habits, sleep-disordered breathing (SDB), and psychiatric problems in children with cancer compared to a control group (sibling). A secondary objective was to assess the influence of hospitalization and psychological status on sleep-disordered breathing and overall sleep quality. Methods In this prospective case–control study, children aged 8–18 years receiving cancer treatment and their healthy siblings completed validated sleep and psychological questionnaires (PSQI, CSHQ, STAI-C, CDI). Objective assessment of sleep-disordered breathing was performed using home-based peripheral arterial tonometry. Patients were monitored during hospitalization and at home, while controls were assessed at home. Apnea–hypopnea index, respiratory disturbance index, and oxygen desaturation index were analyzed as objective outcomes. Results Thirty-seven participants were included (23 patients, 14 controls). Disturbed sleep habits were highly prevalent across the cohort (89.2% on CSHQ). Trait anxiety was significantly higher in patients than in siblings. No significant differences were observed between home and hospital measurements among patients. However, compared with controls, patients demonstrated substantially higher AHI, RDI, and ODI values. Subjective sleep quality (PSQI) classified 27% of the cohort as poor sleepers. Conclusions Pediatric oncology patients experience impaired sleep and increased respiratory disturbances compared with siblings, independent of the hospital environment. Routine screening and early management of sleep problems should be incorporated into pediatric cancer care. Home-based objective sleep monitoring may provide a feasible approach for detecting clinically relevant sleep disturbances in this vulnerable population.
- 14 March 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (2) , 93
Open AccessSleep and psychiatric problems in pediatric oncology patients: A case–control study
Objective This study primarily aimed to investigate sleep habits, sleep-disordered breathing (SDB), and psychiatric problems in children with cancer compared to a control group (sibling). A secondary objective was to assess the influence of hospitalization and psychological status on sleep-disordered breathing and overall sleep quality. Methods In this prospective case–control study, children aged 8–18 years receiving cancer treatment and their healthy siblings completed validated sleep and psychological questionnaires (PSQI, CSHQ, STAI-C, CDI). Objective assessment of sleep-disordered breathing was performed using home-based peripheral arterial tonometry. Patients were monitored during hospitalization and at home, while controls were assessed at home. Apnea–hypopnea index, respiratory disturbance index, and oxygen desaturation index were analyzed as objective outcomes. Results Thirty-seven participants were included (23 patients, 14 controls). Disturbed sleep habits were highly prevalent across the cohort (89.2% on CSHQ). Trait anxiety was significantly higher in patients than in siblings. No significant differences were observed between home and hospital measurements among patients. However, compared with controls, patients demonstrated substantially higher AHI, RDI, and ODI values. Subjective sleep quality (PSQI) classified 27% of the cohort as poor sleepers. Conclusions Pediatric oncology patients experience impaired sleep and increased respiratory disturbances compared with siblings, independent of the hospital environment. Routine screening and early management of sleep problems should be incorporated into pediatric cancer care. Home-based objective sleep monitoring may provide a feasible approach for detecting clinically relevant sleep disturbances in this vulnerable population.
- Open Access
- 27 November 2023
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 17 (6) , 455-460
Efficacy of Cefoperazone-Sulbactam as Empirical Monotherapy Therapy for Febrile Neutropenia in Children with Solid Tumors and Lymphomas
Objective: Monotherapy with a beta lactam or a cephalosporin has become the standard of care for the treatment of febrile neutropenia (FEN). We aimed to evaluate the efficacy of cefoperazone/sulbactam (CS) as empirical monotherapy for febrile neutropenia in children with solid tumors and lymphomas. Material and Methods: Children with FEN received cefaperazone-sulbactam (80 mg/kg/day, every 8 hours). Treatment responses (a) successful, complete resolution of all signs and symptoms of infection at 72 hours and after 7 days of CS treatment; (b) success with modification, change of therapy for viral, parasitic or fungal infection or addition of glycopeptides; (c) failure was defined as the emergence of a new or resistant infection, treatment-resistant bacteremia, the need to switch to carbapenems. Results: Our study included 157 patients and 350 febrile neutropenia episodes. The most common diagnoses were osteosarcoma (35%), Ewing sarcoma (30%), non-hodgkin lymphoma (13%) and rhabdomyosarcoma (9%), respectively. The origin of fever could not be determined in 223 (64%) of FEN episodes, 79 (22%) had microbiologically documented infection (MDI), and 48 (14%) had clinically documented infection (CDI). The success rate was 65% (229), the success rate with modification was 9% (31) and the failure rate was 26% (90). SC monotherapy was successful in 33% of attacks with MDI and in 60% of attacks with CDI. However, SC monotherapy was successful in 82% of febrile episodes of unknown origin. Conclusion: Cefoperazone/sulbactam is effective and safe in febrile neutropenic children with solid tumors and lymphomas for monotherapy.
- 27 November 2023
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 17 (6) , 455-460
Open AccessEfficacy of Cefoperazone-Sulbactam as Empirical Monotherapy Therapy for Febrile Neutropenia in Children with Solid Tumors and Lymphomas
Objective: Monotherapy with a beta lactam or a cephalosporin has become the standard of care for the treatment of febrile neutropenia (FEN). We aimed to evaluate the efficacy of cefoperazone/sulbactam (CS) as empirical monotherapy for febrile neutropenia in children with solid tumors and lymphomas. Material and Methods: Children with FEN received cefaperazone-sulbactam (80 mg/kg/day, every 8 hours). Treatment responses (a) successful, complete resolution of all signs and symptoms of infection at 72 hours and after 7 days of CS treatment; (b) success with modification, change of therapy for viral, parasitic or fungal infection or addition of glycopeptides; (c) failure was defined as the emergence of a new or resistant infection, treatment-resistant bacteremia, the need to switch to carbapenems. Results: Our study included 157 patients and 350 febrile neutropenia episodes. The most common diagnoses were osteosarcoma (35%), Ewing sarcoma (30%), non-hodgkin lymphoma (13%) and rhabdomyosarcoma (9%), respectively. The origin of fever could not be determined in 223 (64%) of FEN episodes, 79 (22%) had microbiologically documented infection (MDI), and 48 (14%) had clinically documented infection (CDI). The success rate was 65% (229), the success rate with modification was 9% (31) and the failure rate was 26% (90). SC monotherapy was successful in 33% of attacks with MDI and in 60% of attacks with CDI. However, SC monotherapy was successful in 82% of febrile episodes of unknown origin. Conclusion: Cefoperazone/sulbactam is effective and safe in febrile neutropenic children with solid tumors and lymphomas for monotherapy.
- Open Access
- 11 March 2022
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- p. 1-7
The Effect of Cord Blood Vitamin D Level on Bronchopulmonary Dysplasia and Other Neonatal Morbidities in Preterm Infants
OBJECTIVES: We aimed to investigate the relationship between cord 25-hydroxyvitamin D level and bronchopulmonary dysplasia and other neonatal morbidities (sepsis, necrotizing enterocolitis, intraventricular hemorrhage, patent ductus arteriosus, respiratory distress syndrome, retinopathy of prematurity) in preterm neonates. STUDY DESIGN: Infants aged RESULTS: Sixty premature infants were analyzed in this study. The mean cord 25-hydroxyvitamin D level was 13,8±6,8 ng/mL (range 3,5-30,7 ng/mL). Eighty percent of the patients (48/60) had 25-hydroxyvitamin D levels CONCLUSION: This study shows the high rate of vitamin D deficiency in pregnant women in the central Anatolian region (Sivas) of Turkey. Low cord 25-hydroxyvitamin D levels were associated with an increased risk of bronchopulmonary dysplasia and prolonged hospitalization in very preterm infants. These data strengthen the necessity for vitamin D supplementation during pregnancy.
- 11 March 2022
- Published by Mebas Medikal Basin Yayin Ltd. Sti in Gynecology Obstetrics & Reproductive Medicine
- p. 1-7
Open AccessThe Effect of Cord Blood Vitamin D Level on Bronchopulmonary Dysplasia and Other Neonatal Morbidities in Preterm Infants
OBJECTIVES: We aimed to investigate the relationship between cord 25-hydroxyvitamin D level and bronchopulmonary dysplasia and other neonatal morbidities (sepsis, necrotizing enterocolitis, intraventricular hemorrhage, patent ductus arteriosus, respiratory distress syndrome, retinopathy of prematurity) in preterm neonates. STUDY DESIGN: Infants aged RESULTS: Sixty premature infants were analyzed in this study. The mean cord 25-hydroxyvitamin D level was 13,8±6,8 ng/mL (range 3,5-30,7 ng/mL). Eighty percent of the patients (48/60) had 25-hydroxyvitamin D levels CONCLUSION: This study shows the high rate of vitamin D deficiency in pregnant women in the central Anatolian region (Sivas) of Turkey. Low cord 25-hydroxyvitamin D levels were associated with an increased risk of bronchopulmonary dysplasia and prolonged hospitalization in very preterm infants. These data strengthen the necessity for vitamin D supplementation during pregnancy.
- Open Access
- 18 March 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (2) , 176-184
ALTI AY- BEŞ YAŞ ARASI ÇOCUKLARDA DEMİR EKSİKLİĞİ VE BESLENME İLİŞKİSİ
Amaç: Demir eksikliği (DE) ve demir eksikliği anemisi (DEA) en sık besinsel eksiklik olup, çocuklardafiziksel ve kognitif gelişim üzerinde olumsuz etkiler doğurabilmektedir. Özellikle yaşamın ilk yıllarındaki beslenme DE/DEA ile doğrudan ilişkilidir. Bu çalışmadaki amacımız, 6 ay-5 yaş arasındaki sağlıklı çocuklarda beslenme ile DE/DEA arasındaki ilişkiyi araştırmaktır. Gereç ve Yöntemler: Çalışmamız, Eylül 2014 - Eylül 2016 tarihlerinde Sivas Cumhuriyet Üniversitesi TıpFakültesi Hastanesi, Pediatri Polikliniğine başvuran 6 ay-5 yaştaki çocuklarda gerçekleştirilmiştir. Çocuklar tam kan sayımı, serum demir düzeyi, total demir bağlama kapasitesi, serum ferritin düzeyi ölçülerek iki gruba ayrılmıştır. Grup 1; DE/DEA olanlar, Grup 2; normal çocuklardan oluşmaktadır. Çocukların beslenmeözellikleri annelerinden öğrenilmiştir. Bulgular: Çalışmamızda toplam187 çocuk yer almıştır (Grup 1=88, Grup 2=99). Her iki grupta çocuklarıncinsiyet ve yaş ortalamaları benzerdir (sırasıyla 22,68±14,22 ve 21,77±13,27 ay, p>0,05). Grup 2’deki çocukların doğum ağırlığı daha fazla (sırasıyla 3091,07±487,78 ve 3268,68±509,28 gr, p<0,05) ve doğum haftası daha geçtir (38,46±1,19 ve 38,82±1,24 hafta,p0,05), sadece anne sütü ile beslenme süresi Grup 1’de daha uzundur (sırasıyla 5,74±2,89 ve 4,36±2,15 ay, p<0,05). Grup 1’deki çocukların ek besine başlama zamanları daha geçtir. Çocukların demir durumu ile tüketilen beyaz peynir, kaşar, lor ve labne peyniri, yumurta, kırmızı et, tavuk ve balık, ev yoğurdu ve sebze yemekleri arasında pozitif korelasyon, yemek suyu, hazır çorba, hazır meyve suyu ve siyah çay tüketimi ile ise negatif korelasyon saptanmıştır. Sonuç: Çocuklarda DE/DEA ile beslenme arasında yakın bir ilişki vardır. Çocukların DE/DEA nden korunmasıiçin annelerin demir deposunun yeterli olması, anne sütüyle beslenme, doğru zamanda demir içeriği zengin ve biyoyararlanımı yüksek besinlerle tamamlayıcı beslenmeye geçiş ve düzenli takip önemlidir.
- 18 March 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (2) , 176-184
Open AccessALTI AY- BEŞ YAŞ ARASI ÇOCUKLARDA DEMİR EKSİKLİĞİ VE BESLENME İLİŞKİSİ
Amaç: Demir eksikliği (DE) ve demir eksikliği anemisi (DEA) en sık besinsel eksiklik olup, çocuklardafiziksel ve kognitif gelişim üzerinde olumsuz etkiler doğurabilmektedir. Özellikle yaşamın ilk yıllarındaki beslenme DE/DEA ile doğrudan ilişkilidir. Bu çalışmadaki amacımız, 6 ay-5 yaş arasındaki sağlıklı çocuklarda beslenme ile DE/DEA arasındaki ilişkiyi araştırmaktır. Gereç ve Yöntemler: Çalışmamız, Eylül 2014 - Eylül 2016 tarihlerinde Sivas Cumhuriyet Üniversitesi TıpFakültesi Hastanesi, Pediatri Polikliniğine başvuran 6 ay-5 yaştaki çocuklarda gerçekleştirilmiştir. Çocuklar tam kan sayımı, serum demir düzeyi, total demir bağlama kapasitesi, serum ferritin düzeyi ölçülerek iki gruba ayrılmıştır. Grup 1; DE/DEA olanlar, Grup 2; normal çocuklardan oluşmaktadır. Çocukların beslenmeözellikleri annelerinden öğrenilmiştir. Bulgular: Çalışmamızda toplam187 çocuk yer almıştır (Grup 1=88, Grup 2=99). Her iki grupta çocuklarıncinsiyet ve yaş ortalamaları benzerdir (sırasıyla 22,68±14,22 ve 21,77±13,27 ay, p>0,05). Grup 2’deki çocukların doğum ağırlığı daha fazla (sırasıyla 3091,07±487,78 ve 3268,68±509,28 gr, p<0,05) ve doğum haftası daha geçtir (38,46±1,19 ve 38,82±1,24 hafta,p0,05), sadece anne sütü ile beslenme süresi Grup 1’de daha uzundur (sırasıyla 5,74±2,89 ve 4,36±2,15 ay, p<0,05). Grup 1’deki çocukların ek besine başlama zamanları daha geçtir. Çocukların demir durumu ile tüketilen beyaz peynir, kaşar, lor ve labne peyniri, yumurta, kırmızı et, tavuk ve balık, ev yoğurdu ve sebze yemekleri arasında pozitif korelasyon, yemek suyu, hazır çorba, hazır meyve suyu ve siyah çay tüketimi ile ise negatif korelasyon saptanmıştır. Sonuç: Çocuklarda DE/DEA ile beslenme arasında yakın bir ilişki vardır. Çocukların DE/DEA nden korunmasıiçin annelerin demir deposunun yeterli olması, anne sütüyle beslenme, doğru zamanda demir içeriği zengin ve biyoyararlanımı yüksek besinlerle tamamlayıcı beslenmeye geçiş ve düzenli takip önemlidir.
- 1 December 2018
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 116 (6) , E736-E742
Is there an association between vitamin D level and iron deficiency in children?
Introduction. Vitamin D (VitD) affects the erythropoiesis. The aim of this study was to evaluate the association between maternal/child 25-OH VitD (25-OHD) levels and iron deficiency (ID) and anemia (IDA) in children aged 6 months-5 years. Population and methods. Between September 2014 and January 2016 children who were admitted to outpatient clinic were included to study. We excluded the children with acute or chronic infection, malnutrition, chronic disease and preterm birth history. Complete blood count, serum iron, total iron binding capacity, ferritin, 25-OHD levels were examined from children and their mothers. Iron and VitD supplementation during infancy and pregnancy and breastfeeding history were questioned. Results. The study included totally 117 children. There were 67 children with ID/IDA [Group 1, mean age (years): 2.05 +/- 1.24 (0.5-5)] and 50 normal children [Group 2, mean age (years): 1.87 +/- 1.12 (0.58-5)]. There were more VitD deficient children and mothers in Group 1 than in Group 2 (respectively, children 49.3 % vs. 20 % p=0.002; mothers 94 % vs. 64 %, p=<0.001). There was a positive correlation between hemoglobin levels of children and maternal/child 25-OHD. The independent risk factors for IDA in children were longer exclusively breastfeeding time (odds ratio [OR], 0.35; 95 % confidence interval [CI], 0.155-0.789; p=0.011), shorter duration of regular iron supplementation during infancy and pregnancy (infancy: OR, 1.69; 95 % CI 1.148-2.508; p=0.008. pregnancy: OR, 1.39; 95 % CI, 1.070-1.820; p=0.014) and lower maternal 25-OHD level (OR, 1.16; 95 % CI, 1.034-1.292; p=0.011). Conclusions. Maternal/child VitD deficiency is associated with ID/IDA in children aged 6 months-5 years.
- 1 December 2018
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 116 (6) , E736-E742
Is there an association between vitamin D level and iron deficiency in children?
Introduction. Vitamin D (VitD) affects the erythropoiesis. The aim of this study was to evaluate the association between maternal/child 25-OH VitD (25-OHD) levels and iron deficiency (ID) and anemia (IDA) in children aged 6 months-5 years. Population and methods. Between September 2014 and January 2016 children who were admitted to outpatient clinic were included to study. We excluded the children with acute or chronic infection, malnutrition, chronic disease and preterm birth history. Complete blood count, serum iron, total iron binding capacity, ferritin, 25-OHD levels were examined from children and their mothers. Iron and VitD supplementation during infancy and pregnancy and breastfeeding history were questioned. Results. The study included totally 117 children. There were 67 children with ID/IDA [Group 1, mean age (years): 2.05 +/- 1.24 (0.5-5)] and 50 normal children [Group 2, mean age (years): 1.87 +/- 1.12 (0.58-5)]. There were more VitD deficient children and mothers in Group 1 than in Group 2 (respectively, children 49.3 % vs. 20 % p=0.002; mothers 94 % vs. 64 %, p=<0.001). There was a positive correlation between hemoglobin levels of children and maternal/child 25-OHD. The independent risk factors for IDA in children were longer exclusively breastfeeding time (odds ratio [OR], 0.35; 95 % confidence interval [CI], 0.155-0.789; p=0.011), shorter duration of regular iron supplementation during infancy and pregnancy (infancy: OR, 1.69; 95 % CI 1.148-2.508; p=0.008. pregnancy: OR, 1.39; 95 % CI, 1.070-1.820; p=0.014) and lower maternal 25-OHD level (OR, 1.16; 95 % CI, 1.034-1.292; p=0.011). Conclusions. Maternal/child VitD deficiency is associated with ID/IDA in children aged 6 months-5 years.
- Open Access
- 1 January 2018
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 60 (1) , 102-106
Pediatric primary anaplastic ganglioglioma with malignant neuronal component
Gangliogliomas (GGs) represent approximately 0.4%-1.0% of all brain tumors. Anaplastic gangliogliomas (AGGs) form 5-10% of all GGs. They are a mixed neuronal-glial tumor of central nervous system and composed by two cell lines; neuronal (ganglionic) and glial cells. Anaplastic component of AGGs is usually glial cells. Malignant neuronal component is a rare condition. Here we report an 8-year-old male patient who was diagnosed with primary AGG with malignant neuronal component and was treated with surgery, adjuvant radiotherapy and chemotherapy.
- 1 January 2018
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 60 (1) , 102-106
Open AccessPediatric primary anaplastic ganglioglioma with malignant neuronal component
Gangliogliomas (GGs) represent approximately 0.4%-1.0% of all brain tumors. Anaplastic gangliogliomas (AGGs) form 5-10% of all GGs. They are a mixed neuronal-glial tumor of central nervous system and composed by two cell lines; neuronal (ganglionic) and glial cells. Anaplastic component of AGGs is usually glial cells. Malignant neuronal component is a rare condition. Here we report an 8-year-old male patient who was diagnosed with primary AGG with malignant neuronal component and was treated with surgery, adjuvant radiotherapy and chemotherapy.
- 24 February 2017
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 33 (4) , 552-558
The Impact of Transfusion and Chelation on Oxidative Stress in Immigrant Syrian Children with β-Thalassemia
Iron overload in β-thalassemia major and intermedia patients leads to oxidative stress and causes to formation of lipid hydroperoxides. Thiobarbituric acid reactive substances (TBARS) are a well established method for screening and monitoring of lipid peroxidation. We aimed to investigate serum TBARS and its relationship with biochemical and hematologic parameters of Turkish and immigrant Syrian β-thalassemia children reflecting the effects of this socioeconomic condition on follow up of these patients. Lipid peroxidation products (TBARS) of Turkish (TR) (n = 62, from the cities of Gaziantep and Sivas, Turkey) and Syrian (SYR) (n = 34, from Gaziantep, Turkey) β-thalassemia patients aged 2–17 years and 58 healthy subjects aged 2–16 years were studied. Liver and renal function tests, serum ferritin levels, white blood cell, absolute neutrophil and platelet counts, hemoglobin (Hb) levels of the patients were analyzed. Serum TBARS concentrations were found to be elevated in β-thalassemia patients compared to healthy subjects (mean: 12.47 ± 8.53 vs. 9.78 ± 7.09, p = 0.045). In SYR patients mean pretransfusional Hb level (7.26.2.04 vs. 8.49 ± 1.01, p = 0.002) was lower and ferritin levels (5983.56 ± 5065.56 vs. 3234.60 ± 2237.82, p = 0.001), liver enzymes (ALT: 77.82 ± 76.48 vs. 42.13 ± 51.50, p = 0.005) were higher when compared to TR group. Positive correlation between TBARS and ferritin levels (p = 0.029, r = 0.231) and liver enzymes (for ALT p < 0.001, r = 0.373) was observed. β-thalassemia patients are under more oxidative stress than healthy subjects. Liver is one of the major organs which are mainly affected by oxidative stress. War and migration might have caused inappropriate transfusion conditions and insufficient chelation therapy in the SYR group.
- 24 February 2017
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 33 (4) , 552-558
The Impact of Transfusion and Chelation on Oxidative Stress in Immigrant Syrian Children with β-Thalassemia
Iron overload in β-thalassemia major and intermedia patients leads to oxidative stress and causes to formation of lipid hydroperoxides. Thiobarbituric acid reactive substances (TBARS) are a well established method for screening and monitoring of lipid peroxidation. We aimed to investigate serum TBARS and its relationship with biochemical and hematologic parameters of Turkish and immigrant Syrian β-thalassemia children reflecting the effects of this socioeconomic condition on follow up of these patients. Lipid peroxidation products (TBARS) of Turkish (TR) (n = 62, from the cities of Gaziantep and Sivas, Turkey) and Syrian (SYR) (n = 34, from Gaziantep, Turkey) β-thalassemia patients aged 2–17 years and 58 healthy subjects aged 2–16 years were studied. Liver and renal function tests, serum ferritin levels, white blood cell, absolute neutrophil and platelet counts, hemoglobin (Hb) levels of the patients were analyzed. Serum TBARS concentrations were found to be elevated in β-thalassemia patients compared to healthy subjects (mean: 12.47 ± 8.53 vs. 9.78 ± 7.09, p = 0.045). In SYR patients mean pretransfusional Hb level (7.26.2.04 vs. 8.49 ± 1.01, p = 0.002) was lower and ferritin levels (5983.56 ± 5065.56 vs. 3234.60 ± 2237.82, p = 0.001), liver enzymes (ALT: 77.82 ± 76.48 vs. 42.13 ± 51.50, p = 0.005) were higher when compared to TR group. Positive correlation between TBARS and ferritin levels (p = 0.029, r = 0.231) and liver enzymes (for ALT p < 0.001, r = 0.373) was observed. β-thalassemia patients are under more oxidative stress than healthy subjects. Liver is one of the major organs which are mainly affected by oxidative stress. War and migration might have caused inappropriate transfusion conditions and insufficient chelation therapy in the SYR group.
- Open Access
- 13 December 2015
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 37 (4) , 287
Is high dose levetiracetam safe in the management of neonatal convulsion?
- 13 December 2015
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 37 (4) , 287
Open AccessIs high dose levetiracetam safe in the management of neonatal convulsion?